BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 21453388)

  • 41. In vivo expression of human T-lymphotropic virus type 1 basic leucine-zipper protein generates specific CD8+ and CD4+ T-lymphocyte responses that correlate with clinical outcome.
    Hilburn S; Rowan A; Demontis MA; MacNamara A; Asquith B; Bangham CR; Taylor GP
    J Infect Dis; 2011 Feb; 203(4):529-36. PubMed ID: 21208912
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Adult T-cell leukemia/lymphoma diagnosed by RNA in situ hybridization for HTLV-1 bZIP factor].
    Nakamura T; Yasunaga JI; Yokoo K; Takatori M; Kawakami F; Higuchi Y; Tatetsu H; Nosaka K; Karube K; Mikami Y; Matsuoka M
    Rinsho Ketsueki; 2022; 63(2):89-93. PubMed ID: 35264507
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dual cytoplasmic and nuclear localization of HTLV-1-encoded HBZ protein is a unique feature of adult T-cell leukemia.
    Forlani G; Shallak M; Tedeschi A; Cavallari I; Marçais A; Hermine O; Accolla RS
    Haematologica; 2021 Aug; 106(8):2076-2085. PubMed ID: 33626865
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HTLV-1 HBZ positively regulates the mTOR signaling pathway via inhibition of GADD34 activity in the cytoplasm.
    Mukai R; Ohshima T
    Oncogene; 2014 May; 33(18):2317-28. PubMed ID: 23708656
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cytotoxic T lymphocyte lysis of HTLV-1 infected cells is limited by weak HBZ protein expression, but non-specifically enhanced on induction of Tax expression.
    Rowan AG; Suemori K; Fujiwara H; Yasukawa M; Tanaka Y; Taylor GP; Bangham CR
    Retrovirology; 2014 Dec; 11():116. PubMed ID: 25499803
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enhancement of infectivity and persistence in vivo by HBZ, a natural antisense coded protein of HTLV-1.
    Arnold J; Yamamoto B; Li M; Phipps AJ; Younis I; Lairmore MD; Green PL
    Blood; 2006 May; 107(10):3976-82. PubMed ID: 16424388
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HTLV-1 bZIP factor gene: Its roles in HTLV-1 pathogenesis.
    Matsuoka M
    Mol Aspects Med; 2010 Oct; 31(5):359-66. PubMed ID: 20599553
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multifaceted functions and roles of HBZ in HTLV-1 pathogenesis.
    Ma G; Yasunaga J; Matsuoka M
    Retrovirology; 2016 Mar; 13():16. PubMed ID: 26979059
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [HTLV-1 bZIP Factor (HBZ): Roles in HTLV-1 Oncogenesis].
    Wu W; Cheng W; Chen M; Xu L; Zhao T
    Bing Du Xue Bao; 2016 Mar; 32(2):235-42. PubMed ID: 27396170
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinicopathological features of adult T-cell leukemia/lymphoma with HTLV-1-infected Hodgkin and Reed-Sternberg-like cells.
    Karube K; Takatori M; Sakihama S; Tsuruta Y; Miyagi T; Morichika K; Kitamura S; Nakada N; Hayashi M; Tomori S; Nakazato I; Ohshiro K; Imaizumi N; Kikuti YY; Nakamura N; Morishima S; Masuzaki H; Fukushima T
    Blood Adv; 2021 Jan; 5(1):198-206. PubMed ID: 33570645
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: viral infectivity, Tax, HBZ and therapy.
    Matsuoka M; Jeang KT
    Oncogene; 2011 Mar; 30(12):1379-89. PubMed ID: 21119600
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The HTLV-1 hbz antisense gene indirectly promotes tax expression via down-regulation of p30(II) mRNA.
    Choudhary G; Ratner L
    Virology; 2011 Feb; 410(2):307-15. PubMed ID: 21176937
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human T-cell leukemia virus type-1-encoded protein HBZ represses p53 function by inhibiting the acetyltransferase activity of p300/CBP and HBO1.
    Wright DG; Marchal C; Hoang K; Ankney JA; Nguyen ST; Rushing AW; Polakowski N; Miotto B; Lemasson I
    Oncotarget; 2016 Jan; 7(2):1687-706. PubMed ID: 26625199
    [TBL] [Abstract][Full Text] [Related]  

  • 54. HTLV-1 bZIP factor-specific CD4 T cell responses in adult T cell leukemia/lymphoma patients after allogeneic hematopoietic stem cell transplantation.
    Narita T; Ishida T; Masaki A; Suzuki S; Ito A; Mori F; Yamada T; Ri M; Kusumoto S; Komatsu H; Miyazaki Y; Takatsuka Y; Utsunomiya A; Niimi A; Iida S; Ueda R
    J Immunol; 2014 Feb; 192(3):940-7. PubMed ID: 24363428
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HTLV-1 bZIP factor suppresses apoptosis by attenuating the function of FoxO3a and altering its localization.
    Tanaka-Nakanishi A; Yasunaga J; Takai K; Matsuoka M
    Cancer Res; 2014 Jan; 74(1):188-200. PubMed ID: 24177179
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HTLV-1 basic leucine-zipper factor, HBZ, interacts with MafB and suppresses transcription through a Maf recognition element.
    Ohshima T; Mukai R; Nakahara N; Matsumoto J; Isono O; Kobayashi Y; Takahashi S; Shimotohno K
    J Cell Biochem; 2010 Sep; 111(1):187-94. PubMed ID: 20506502
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification and characterization of HTLV-1 HBZ post-translational modifications.
    Dissinger N; Shkriabai N; Hess S; Al-Saleem J; Kvaratskhelia M; Green PL
    PLoS One; 2014; 9(11):e112762. PubMed ID: 25389759
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transcriptional control of spliced and unspliced human T-cell leukemia virus type 1 bZIP factor (HBZ) gene.
    Yoshida M; Satou Y; Yasunaga J; Fujisawa J; Matsuoka M
    J Virol; 2008 Oct; 82(19):9359-68. PubMed ID: 18653454
    [TBL] [Abstract][Full Text] [Related]  

  • 59. HTLV-1 viral oncogene HBZ drives bone destruction in adult T cell leukemia.
    Xiang J; Rauch DA; Huey DD; Panfil AR; Cheng X; Esser AK; Su X; Harding JC; Xu Y; Fox GC; Fontana F; Kobayashi T; Su J; Sundaramoorthi H; Wong WH; Jia Y; Rosol TJ; Veis DJ; Green PL; Niewiesk S; Ratner L; Weilbaecher KN
    JCI Insight; 2019 Oct; 4(19):. PubMed ID: 31578308
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interplay between innate immunity and the viral oncoproteins Tax and HBZ in the pathogenesis and therapeutic response of HTLV-1 associated adult T cell leukemia.
    El Hajj H; Bazarbachi A
    Front Immunol; 2022; 13():957535. PubMed ID: 35935975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.